An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information.* New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance Precision Diabetes, Inc. announces new studies that show that the GlycoMark blood test, which measures 1,5-anhydroglucitol, may be useful for evaluating short-term effectiveness and assessing...
Author: Mark Newman
Endocrine Society Recommendations Incorporated in Draft UN Plastics Treaty
On September 6, the United Nations Environment Programme (UNEP) Secretariat released the initial “zero” draft of a treaty to address plastic pollution. The zero draft is a starting point for more detailed negotiations that will resume this month at the third session of the Intergovernmental Negotiating Committee (INC3) to develop an international legally binding instrument...
Despite being inducted into what he calls the “Endocrine Hall of Fame” upon receiving this year’s Fred Conrad Koch Lifetime Achievement Award, Mitchell A. Lazar, MD, PhD, reflects on his achievements and his legacy. However, he wants to make sure that despite such lofty recognition, he assures us that he still has “a couple of...
Endocrine Society Continues to Advocate for Insulin Affordability
The Endocrine Society continues to advocate for insulin affordability. Although new legislation to make insulin more affordable has been stalled in Congress, the Centers for Medicare and Medicaid Services (CMS) continues to advance a program to implement drug price negotiations to lower the cost of certain prescription drugs, including several diabetes medications. CMS recently hosted...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * FDA Approves sNDA for Pediatric Achondroplasia Drug On October 20, the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for VOXZOGO® (vosoritide) to increase linear growth in pediatric patients with achondroplasia with open epiphyses (growth plates)....
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Spruce Biosciences Focuses on CAH in Clinical Trial On October 18, Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, announced completion of target enrollment of 72...
Felix Beuschlein Receives 2024 Transatlantic Alliance Award in Endocrinology
The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce that they have awarded the 2024 Transatlantic Alliance Award to Professor Felix Beuschlein, MD. Beuschlein is professor of internal medicine/endocrinology and director of the Clinic for Endocrinology, Diabetology, and Clinical Nutrition at the University Clinic Zurich in Switzerland. He received his...
Like many of you, one factor that sparked my love of endocrine science and clinical care was observing firsthand my mentors’ passion for the subject. In fact, I can say without a doubt that a month on the inpatient service at the San Francisco VA Hospital with Dolores Shoback was the turning point that steered...